Yudin Mark H, Kaul Rupert
Department of Obstetrics and Gynecology, St. Michael's Hospital, Toronto, ON, Canada.
Infect Dis Obstet Gynecol. 2008;2008:592532. doi: 10.1155/2008/592532.
Most HIV-infected individuals are coinfected by Herpes simplex virus type 2 (HSV-2). HSV-2 reactivates more frequently in HIV-coinfected individuals with advanced immunosuppression, and may have very unusual clinical presentations, including hypertrophic genital lesions. We report the case of a progressive, hypertrophic HSV-2 lesion in an HIV-coinfected woman, despite near-complete immune restoration on antiretroviral therapy for up to three years. In this case, there was prompt response to topical imiquimod. The immunopathogenesis and clinical presentation of HSV-2 disease in HIV-coinfected individuals are reviewed, with a focus on potential mechanisms for persistent disease despite apparent immune reconstitution. HIV-infected individuals and their care providers should be aware that HSV-2 may cause atypical disease even in the context of near-comlpete immune reconstitution on HAART.
大多数感染HIV的个体同时感染了2型单纯疱疹病毒(HSV-2)。在免疫抑制严重的HIV合并感染个体中,HSV-2更频繁地复发,并且可能有非常不寻常的临床表现,包括生殖器肥厚性病变。我们报告了一例HIV合并感染的女性患者,尽管接受抗逆转录病毒治疗近三年来免疫功能近乎完全恢复,但仍出现了进行性、肥厚性HSV-2病变。在该病例中,局部应用咪喹莫特后迅速起效。本文回顾了HIV合并感染个体中HSV-2疾病的免疫发病机制和临床表现,重点关注尽管有明显的免疫重建但疾病仍持续存在的潜在机制。HIV感染个体及其护理人员应意识到,即使在接受高效抗逆转录病毒治疗(HAART)后免疫近乎完全重建的情况下,HSV-2仍可能引起非典型疾病。